34 filings
6-K
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
6-K
CMMB
Chemomab Therapeutics Ltd
14 Aug 23
Current report (foreign)
8:05am
6-K
CMMB
Chemomab Therapeutics Ltd
8 Aug 23
Current report (foreign)
6:00am
6-K
fws 74878qvsi
3 Jul 23
Current report (foreign)
3:49pm
6-K
kcssw
21 Nov 19
Consolidated Interim Financial Statements
5:00pm
6-K
hl7khpzjom hlmnxx
15 Nov 19
Current report (foreign)
8:58am
6-K
8ll4swx0
12 Nov 19
Current report (foreign)
5:02pm
6-K
duuan1rn
28 Oct 19
Current report (foreign)
6:50am
6-K
pcso a6zl3cetyrg
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
6-K
0ayfh7i4y7p2e3fcx2d
13 Aug 19
Consolidated Interim Financial Statements
5:15pm
6-K
rbs 7aeoe6
6 Aug 19
Anchiano Therapeutics Reports Second Quarter 2019 Financial Results
9:15am
6-K
2q2ving7m6s37xt6u
8 Jul 19
Current report (foreign)
7:30am
6-K
98j nkoac3
18 Jun 19
Current report (foreign)
8:30am
6-K
0j8ado9us q68
28 May 19
Notice of Annual General Meeting of Shareholders of the Company
5:26pm
6-K
blocfynv6tr8 69
22 May 19
Anchiano Therapeutics Reports First Quarter 2019 Financial Results
9:00am
6-K
x7npm7h
14 Mar 19
Current report (foreign)
7:00am
6-K
hfg9h8zuhclr
12 Mar 19
Anchiano Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
4:15pm
6-K
2yacvoui
14 Feb 19
Current report (foreign)
4:40pm